BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 18855574)

  • 1. Cancer therapy: targeting cell cycle regulators.
    Johansson M; Persson JL
    Anticancer Agents Med Chem; 2008 Oct; 8(7):723-31. PubMed ID: 18855574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclins and related kinases in cancer cells.
    Malumbres M
    J BUON; 2007 Sep; 12 Suppl 1():S45-52. PubMed ID: 17935277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Cyclin-Dependent Kinases and Cell Cycle Progression in Human Cancers.
    Santo L; Siu KT; Raje N
    Semin Oncol; 2015 Dec; 42(6):788-800. PubMed ID: 26615126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs.
    Roskoski R
    Pharmacol Res; 2016 May; 107():249-275. PubMed ID: 26995305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin-dependent kinase inhibition: an opportunity to target protein-protein interactions.
    Klein MA
    Adv Protein Chem Struct Biol; 2020; 121():115-141. PubMed ID: 32312419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer.
    Vermeulen K; Van Bockstaele DR; Berneman ZN
    Cell Prolif; 2003 Jun; 36(3):131-49. PubMed ID: 12814430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclins and CDKS in development and cancer: lessons from genetically modified mice.
    Santamaria D; Ortega S
    Front Biosci; 2006 Jan; 11():1164-88. PubMed ID: 16146805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective inhibition of proteins regulating CDK/cyclin complexes: strategy against cancer--a review.
    Sarita Rajender P; Ramasree D; Bhargavi K; Vasavi M; Uma V
    J Recept Signal Transduct Res; 2010 Aug; 30(4):206-13. PubMed ID: 20560705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin-dependent kinase modulators and cancer therapy.
    Gallorini M; Cataldi A; di Giacomo V
    BioDrugs; 2012 Dec; 26(6):377-91. PubMed ID: 22928661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting cyclins and cyclin-dependent kinases in cancer: lessons from mice, hopes for therapeutic applications in human.
    Lee YM; Sicinski P
    Cell Cycle; 2006 Sep; 5(18):2110-4. PubMed ID: 16969111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell cycle control as a basis for cancer drug development (Review).
    McDonald ER; El-Deiry WS
    Int J Oncol; 2000 May; 16(5):871-86. PubMed ID: 10762622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research on cyclin-dependent kinase inhibitors: state of the art and perspective].
    Zuo MX; Chen XG
    Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):321-4. PubMed ID: 17892123
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs.
    Roskoski R
    Pharmacol Res; 2019 Jan; 139():471-488. PubMed ID: 30508677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the cell cycle: a new approach to cancer therapy.
    Schwartz GK; Shah MA
    J Clin Oncol; 2005 Dec; 23(36):9408-21. PubMed ID: 16361640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin-dependent kinase inhibitors for the treatment of chronic lymphocytic leukemia.
    Blachly JS; Byrd JC; Grever M
    Semin Oncol; 2016 Apr; 43(2):265-73. PubMed ID: 27040705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell Cycle-Related Clinical Applications.
    Khan MGM; Wang Y
    Methods Mol Biol; 2022; 2579():35-46. PubMed ID: 36045196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycle regulators in cancer cell metabolism.
    Leal-Esteban LC; Fajas L
    Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165715. PubMed ID: 32035102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer therapeutic strategies based on CDK inhibitors.
    Esposito L; Indovina P; Magnotti F; Conti D; Giordano A
    Curr Pharm Des; 2013; 19(30):5327-32. PubMed ID: 23394082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspectives on cancer therapy: cell cycle blockers and perturbators.
    Dobashi Y; Takehana T; Ooi A
    Curr Med Chem; 2003 Dec; 10(23):2549-58. PubMed ID: 14529470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin-Dependent Kinases (CDK) and Their Role in Diseases Development-Review.
    Łukasik P; Załuski M; Gutowska I
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.